Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department

American Heart Journal

Volumn 152, Issue 5, 2006, Pages 949-955

  Chung, Tommy ^a   Sindone, Andrew ^a   Foo, Fiona ^a   Dwyer, Andrew ^a   Paoloni, Richard ^a   Janu, Margaret R ^a   Wong, Helen ^a   Hall, Judith ^a   Freedman, Saul B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPNEA; EMERGENCY WARD; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN;

EID: 33750326144     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.05.020     Document Type: Article

References (12)

1. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6 (2004) 257-260
2. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure. Circulation 106 (2002) 416-422
3. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
4. Tang W., Girod J.P., Lee M.J., et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108 (2003) 2964-2966
5. Morrison L.K., Harrison A., Krishnaswamy P., et al. Utility of rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
6. Wang T.J., Larson M.G., and Levy D. Impact of age and sex on plasma naturetic peptide levels in healthy adults. Am J Cardiol 90 (2002) 254-258
7. Miller R., Das S., Anandarangam T., et al. Association between right ventricular function and perfusion abnormalities in hemodynamically stable patients with acute pulmonary embolism. Chest 113 (1998) 665-670
8. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type naturetic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 29 (2002) 131-137
9. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type naturetic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 (2001) 379-385
10. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type naturetic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
11. Cotes C.B.J., Leta R., and Casan P. N-terminal probain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6 (2004) 301-308
12. Packer M. Should B-type naturetic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?. Circulation 108 (2003) 2950-2953